Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of infectious and autoimmune diseases
3.2.1.2 Increasing demand for point-of-care testing (POCT)
3.2.1.3 Technological innovations
3.2.1.4 Increasing awareness and screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antibody detection
5.3 Antigen testing
Chapter 6 Market Estimates and Forecast, By Infection Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Streptococcus
6.3 Staphylococcus Aureus
6.4 Escherichia Coli
6.5 Salmonella Spp.
6.6 Other infection types
Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Cerebrospinal fluid
7.5 Other sample types
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Academic and research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Atlas Medical GmbH
10.2 Arlington Scientific, Inc
10.3 Bio-Rad Laboratories, Inc.
10.4 bioMérieuxSA
10.5 Biotium
10.6 Creative Diagnostics
10.7 Cardinal Health, Inc.
10.8 Eurofins Scientific Group
10.9 Hardy plc
10.10 HiMedia Laboratories
10.11 Liofilchem S.r.l.
10.12 Novacyt Group
10.13 PerkinElmer, Inc.
10.14 Pro Lab Diagnostics
10.15 Thermo Fisher Scientific Inc.
